Table 1.
Number (%)* | |
---|---|
Age (mean ± SD) | 65.3 ± 10.5 |
Gender (M:F) | 16:5 |
Underlying disease | |
Common bile duct cancer | 8 (38.1%) |
Ampulla of Vater cancer | 4 (19.0%) |
Pancreas cancer | 3 (14.3%) |
Duodenal cancer | 3 (14.3%) |
Intraductal mucinous papillary neoplasm | 2 (9.5%) |
Choledochal cyst | 1 (4.8%) |
Surgical procedure | |
PPPD | 16 (76.2%) |
Whipple’s operation | 5 (23.8%) |
Time Interval from surgery | 4–62 days (median 24) |
Clinical manifestation* | |
Hematemesis | 9 (42.9%) |
Sentinel bleeding | 8 (38.1%) |
Hypotension | 6 (28.6%) |
Hematochezia/melena | 4 (19.0%) |
Abdominal pain | 4 (19.0%) |
Pancreatic fistula (Y:N)a | 11 (52.4%): 10 (47.6%) |
* 10 patients had multiple symptoms |
Defined as grade B or C according to the definition of the International Study Group of Pancreatic Surgery (12)
Among 20 patients in whom covered stent was technically feasible